FIU Discovery

Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment.  Cytotherapy.  28.

Canonical human blood dendritic cells are distinguished by robust E-selectin binding.  JOURNAL OF IMMUNOLOGY.  215.

Glycocalyx-edited mesenchymal stem/stromal cell therapy in advanced osteoporosis.  Cell. 

Latin America and evolving oncotherapeutics using CAR T cells, conjugated antibodies, and bispecific antibodies.  Blood Global Hematology.  1:100007.

Restricted human CD45 isoglycoforms serve as functional E-selectin ligands and delineate hematopoietic maturity.  Journal of Biological Chemistry.  301.

Ganglioside expression delineates human mesenchymal stem/stromal cell populations derived from different tissue sources.  Cytotherapy.  27:446-456.

Enforced E-selectin ligand installation enhances homing and efficacy of adoptively transferred T cells..  bioRxiv. 

Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics.  FRONTIERS IN IMMUNOLOGY.  15.

Enrichment and nLC-MS/MS Analysis of Head and Neck Cancer Mucinome Glycoproteins.  Journal of Proteome Research.  22:1231-1244.

Enrichment and nLC-MS/MS Analysis of Head and Neck Cancer Mucinome Glycoproteins.  Journal of Proteome Research.  1231-1244.

Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  143:456-+.

Multidimensional separation and analysis of alpha-1-acid glycoprotein N-glycopeptides using high-field asymmetric waveform ion mobility spectrometry (FAIMS) and nano-liquid chromatography tandem mass spectrometry.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY.  415:379-390.

The biology of E-selectin ligands in leukemogenesis.  Advances in Cancer Research.  157:229-250.

Enforced mesenchymal stem cell tissue colonization counteracts immunopathology.  npj Regenerative Medicine.  7.

Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia.  FRONTIERS IN IMMUNOLOGY.  13.

Abstract 2400: Fucosyltransferase expression is associated with head and neck cancer survival.  CANCER RESEARCH.  82:2400-2400.

Identification of α1,2-fucosylated signaling and adhesion molecules in head and neck squamous cell carcinoma.  GLYCOBIOLOGY.  32:441-455.

Leptin secreted from testicular microenvironment modulates hedgehog signaling to augment the endogenous function of Leydig cells.  Cell Death and Disease.  13.

Emerging glyco-based strategies to steer immune responses.  The FEBS Journal.  288:4746-4772.

Caring for Vulnerable Communities in Miami Dade County during the COVID-19 Pandemic.  JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED.  32:598-+.

Fucosyltransferase-specific inhibition via next generation of fucose mimetics.  Chemical Communications.  57:1145-1148.

Exofucosylation of Adipose Mesenchymal Stromal Cells Alters Their Secretome Profile.  FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY.  8.

sLeX Expression Delineates Distinct Functional Subsets of Human Blood Central and Effector Memory T Cells.  JOURNAL OF IMMUNOLOGY.  205:1920-+.

The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation.  SCIENTIFIC REPORTS.  10.

Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease.  JOURNAL OF CELLULAR AND MOLECULAR MEDICINE.  24:8031-8044.

β4GALT1 controls β1 integrin function to govern thrombopoiesis and hematopoietic stem cell homeostasis.  NATURE COMMUNICATIONS.  11.

Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding.  JOURNAL OF BIOLOGICAL CHEMISTRY.  294:18465-18474.

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.  FRONTIERS IN IMMUNOLOGY.  10.

Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis.  Nature Cell Biology.  21:627-+.

The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering.  FRONTIERS IN IMMUNOLOGY.  9.

A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast.  Biochimica et Biophysica Acta - General Subjects.  1862:2069-2080.

Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications.  Cytotherapy.  20:1110-1123.

Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration.  JOURNAL OF IMMUNOLOGY.  201:1030-1043.

Distinct human (1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells.  Journal of Biological Chemistry.  293:7300-7314.

Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue.  BMC CANCER.  18.

Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation.  Molecular Oncology.  12:579-593.

Mapping Specific Cellular Sialoglycans Using Glycosyltransferases.  FASEB JOURNAL.  32:673.8-673.8.

Imaging specific cellular glycan structures using glycosyltransferases via click chemistry.  GLYCOBIOLOGY.  28:69-79.

Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression.  SCIENTIFIC REPORTS.  8.

T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.  LABORATORY INVESTIGATION.  97:669-697.

mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitors.  Journal of Clinical Investigation.  127:2433-2437.

Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.  JOURNAL OF IMMUNOLOGY.  198:3576-3587.

A Glycovariant of Human CD44 Is Characteristically Expressed on Human Mesenchymal Stem Cells.  Stem Cells.  35:1080-1092.

Leukocyte-borne α(1,3)-fucose is a negative regulator of β₂-integrin-dependent recruitment in lung inflammation.  JOURNAL OF LEUKOCYTE BIOLOGY.  101:459-470.

Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells.  Stem Cells.  34:2501-2511.

Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis.  GLYCOBIOLOGY.  25:1392-1409.

HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.  Stem Cells.  33:1523-1531.

Western Blot Analysis of Adhesive Interactions Under Fluid Shear Conditions: The Blot Rolling Assay.  Methods in molecular biology (Clifton, N.J.).  1312:399-410.

The mechanisms of up-regulation of dendritic cell activity by oxidative stress.  JOURNAL OF LEUKOCYTE BIOLOGY.  96:283-293.

G-CSF Induces Membrane Expression of a Myeloperoxidase Glycovariant that Operates as an E-selectin Ligand on Human Myeloid Cells.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.  111:10696-10701.

Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect.  Human Molecular Genetics.  23:2880-2887.

CD45/CD11b positive subsets of adult lung anchorage-independent cells harness epithelial stem cells in culture.  Journal of tissue engineering and regenerative medicine.  7:572-583.

Glycoengineering of HCELL, the Human Bone Marrow Homing Receptor: Sweetly Programming Cell Migration.  ANNALS OF BIOMEDICAL ENGINEERING.  40:766-776.

Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice.  BLOOD.  119:1263-1273.

Engineering cellular trafficking via glycosyltransferase- programmed stereosubstitution

Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.  BLOOD.  118:1774-1783.

The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives.  Current Opinion in Hematology.  18:239-248.

Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.  108:2258-2263.

Embryonic stem cell-based therapeutics: balancing scientific progress and bioethics..  Health matrix (Cleveland, Ohio : 1991).  20:203-217.

Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions.  JOURNAL OF LEUKOCYTE BIOLOGY.  86:1285-1294.

Fucosyltransferase VI Induces Platelet Activation: A Novel Property of a Plasma Glycosyltransferase..  BLOOD.  114:4016.

Regulation of Heparan Sulfate and Chondroitin Sulfate Glycosaminoglycan Biosynthesis by 4-Fluoro-glucosamine in Murine Airway Smooth Muscle Cells.  Journal of Biological Chemistry.  284:16832-16839.

Western Blot Analysis of Adhesive Interactions under Fluid Shear Conditions: The Blot Rolling Assay.  Methods in molecular biology (Clifton, N.J.).  536:343-354.

CD15 expression in human myeloid cell differentiation is regulated by sialidase activity.  Nature Chemical Biology.  4:751-757.

SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.  BLOOD.  112:150-158.

L-selectin-mediated lymphocyte-cancer cell interactions under low fluid shear conditions.  Journal of Biological Chemistry.  283:15816-15824.

Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survival.  EXPERIMENTAL HEMATOLOGY.  36:464-472.

Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.  Nature Medicine.  14:181-187.

Ex Vivo Glycan Engineering of Membrane CD44 To Create HCELL Programs Human Mesenchymal Stem Cell Trafficking to Bone..  BLOOD.  110:218.

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.  104:5431-5436.

Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm.  BLOOD.  109:1381-1386.

HCELL Is the Major E- and L-Selectin Ligand Expressed on Human Hematopoietic Progenitor Cells and Colon Carcinoma Cells..  BLOOD.  108:4177.

G-CSF induces E-selectin ligand expression on human myeloid cells.  Nature Medicine.  12:1185-1190.

HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.  Journal of Biological Chemistry.  281:13899-13905.

CD43 is a ligand for E-selectin on CLA⁺ human T cells.  BLOOD.  107:1421-1426.

Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells.  FASEB JOURNAL.  20:337-339.

A revision of Billingham's tenets: The central role of lymphocyte migration in acute graft-versus-host disease.  Transplantation and Cellular Therapy.  12:2-8.

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)..  BLOOD.  106:3665.

The lymphocyte homing receptors: gatekeepers of the multistep paradigm.  Current Opinion in Hematology.  12:444-450.

CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.  CANCER RESEARCH.  65:5812-5817.

Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation.  British Journal of Haematology.  128:351-359.

The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  122:1061-1069.

CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD.  BLOOD.  103:740-742.

Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.  Journal of Clinical Investigation.  112:1008-1018.

Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.  Journal of Clinical Investigation.  112:1008-1018.

Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.  EXPERIMENTAL HEMATOLOGY.  31:609-621.

Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants.  Transplantation and Cellular Therapy.  9:373-382.

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.  Transplantation and Cellular Therapy.  9:320-329.

Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.  BLOOD.  101:602-610.

In vitro adherence of lymphocytes to dennal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD.  BLOOD.  101:771-778.

Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving non-myeloablative conditioning and a haploidentical related allogeneic bone marrow transplant.  Cytokines, Cellular and Molecular Therapy.  7:43-47.

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.  Transplantation.  74:1405-1409.

Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.  Transplantation.  74:1159-1166.

Porcine mononuclear cells adhere to human fibronectin independently of very late antigen-5: implications for donor-specific tolerance induction in xenotransplantation.  XENOTRANSPLANTATION.  9:277-289.

Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots.  JOURNAL OF IMMUNOLOGY.  168:5645-5651.

Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade.  Transplantation.  73:12-22.

Differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1.  Journal of Biological Chemistry.  276:47623-47631.

Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses.  JOURNAL OF IMMUNOLOGY.  167:5531-5534.

Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation.  Transplantation.  71:1601-1609.

CD44 is a major E-selectin ligand on human hematopoietic progenitor cells.  Journal of Cell Biology.  153:1277-1286.

Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy.  Bone Marrow Transplantation.  27:1227-1236.

Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.  Transplantation and Cellular Therapy.  7:604-612.

A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells.  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.  97:13841-13846.

Early CDS T-cell recovery and sensitized cytotoxic T cell response correlate with marrow graft rejection following bone marrow transplantation (BMT) with a nonmyeloablative regimen.  BLOOD.  96.

Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates.  Transplantation.  70:1323-1331.

A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.  BLOOD.  96:2765-2774.

A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan–dependent binding activity.  BLOOD.  96:2765-2774.

Coagulation/thrombotic disorders associated with organ and cell xenotransplantation.  TRANSPLANTATION PROCEEDINGS.  32:1099-1099.

Von Willebrand factor concentration, multimeric patterns, and cleaving protease activity in baboons undergoing xenogeneic peripheral blood stem cell transplantation.  TRANSPLANTATION PROCEEDINGS.  32:990-990.

High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.  Transplantation.  69:2296-2304.

CAN MIXED CHIMERISM BE ACHIEVED WITHOUT GVHD ACROSS HLA BARRIERS USING NON-MYELOABLATIVE CONDITIONING WITH EXHAUSTIVE IN VIVO T CELL DEPLETION? PRELIMINARY EXPERIENCE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES..  Transplantation.  69:s295.

Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine.  Transplantation.  69:135-140.

High-dose cyclophosphamide plus carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study.  Bone Marrow Transplantation.  25:19-24.

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.  Transplantation and Cellular Therapy.  6:309-320.

The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1α.  BLOOD.  94:4233-4246.

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.  Bone Marrow Transplantation.  24:897-902.

Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.  Bone Marrow Transplantation.  24:891-895.

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism.  Transplantation.  68:480-484.

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.  LANCET.  353:1755-1759.

Divergence of integrin function in hematopoiesis in the pig to human xenogeneic combination: implications for bone marrow induced donor-specific tolerance.  EXPERIMENTAL HEMATOLOGY.  26:777.

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.  Bone Marrow Transplantation.  20:653-656.

A hematopoietic cell L-selectin ligand exhibits sulfate-independent binding activity.  BLOOD.  89:2773-2781.

Expression of an L-selectin ligand on hematopoietic progenitor cells.  Acta Haematologica.  97:22-28.

Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2.  Human Pathology.  27:738-744.

EVIDENCE OF POSTTRANSCRIPTIONAL REGULATION OF L-SELECTIN GENE-EXPRESSION IN RAT LYMPHOID-CELLS.  Immunology.  85:198-204.

THE EFFECTS OF CORTICOSTEROIDS ON LYMPHOCYTE RECIRCULATION IN HUMANS - ANALYSIS OF THE MECHANISM OF IMPAIRED LYMPHOCYTE MIGRATION TO LYMPH-NODE FOLLOWING METHYLPREDNISOLONE ADMINISTRATION.  JOURNAL OF INVESTIGATIVE MEDICINE.  43:68-77.

Lymphocyte migration following bone marrow transplantation

Preface.  ANNALS OF THE NEW YORK ACADEMY OF SCIENCES.  770:xi-xi.

Detection of an L-selectin ligand on a hematopoietic progenitor cell line.  BLOOD.  84:3299-3306.

Adoptive Immunotherapy: The Magic Bullet of Cancer Therapy?.  Cancer Control.  1:65-66.

EFFECTS OF METHYLPREDNISOLONE ADMINISTRATION ON LYMPHOCYTE LECAM-1, CD44, AND LFA-1 EXPRESSION - IMPLICATIONS FOR STEROID-INDUCED LYMPHOPENIA.  ANNALS OF THE NEW YORK ACADEMY OF SCIENCES.  696:417-419.

THE ANTITACHYCARDIA PACING ICD - IMPACT ON PATIENT SELECTION AND OUTCOME.  PACE - Pacing and Clinical Electrophysiology.  16:165-169.

LYMPHOCYTE RECOGNITION OF PSORIATIC ENDOTHELIUM - EVIDENCE FOR A TISSUE-SPECIFIC RECEPTOR LIGAND INTERACTION.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  93:S82-S87.

Lymphocyte Recognition of Psoriatic Endothelium: Evidence for a Tissue-Specific Receptor/Ligand Interaction..  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  93:82S-87S.

LYMPHOCYTE ADHESION TO PSORIATIC DERMAL ENDOTHELIUM IS MEDIATED BY A TISSUE-SPECIFIC RECEPTOR LIGAND INTERACTION.  JOURNAL OF INVESTIGATIVE DERMATOLOGY.  91:423-428.

Mechanisms of lymphocyte migration to lymphoid tissues and inflamatory sites.  Clinical Immunology Newsletter.  9:181-184.

Analysis of MHC class III gene expression in murine macrophages.  FEDERATION PROCEEDINGS.  43.

EXPRESSION OF HEMOLYTICALLY ACTIVE MURINE 4TH COMPONENT OF COMPLEMENT IN TRANSFECTED L-CELLS.  Cell.  37:569-576.

MOLECULAR REGULATION OF MHC CLASS-III (C-4 AND FACTOR-B) GENE-EXPRESSION IN MOUSE PERITONEAL-MACROPHAGES.  JOURNAL OF IMMUNOLOGY.  133:1618-1626.

SUBDIVISION OF THE S-REGION OF THE MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX BY IDENTIFICATION OF GENOMIC POLYMORPHISMS OF THE CLASS-III GENES.  IMMUNOGENETICS.  20:321-330.

PHYLOGENETIC CONSERVATION OF A CLASS-III MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN, FACTOR-B - ISOLATION AND NUCLEOTIDE SEQUENCING OF MOUSE FACTOR-B CDNA CLONES.  Journal of Biological Chemistry.  258:4693-4697.

Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells? No!.  Blood Cells, Molecules, and Diseases.  32:106-111.

DIRECTING STEM CELL TRAFFICKING VIA GPS.  93-105.

The Blot Rolling Assay: A Method for Identifying Adhesion Molecules Mediating Binding Under Shear Conditions.  217-226.

Graft-vs-Host Disease.  229-248.

Tissue and species specific regulation of complement biosynthesis in mononuclear phagocytes.  147-155.

Dynamic Expression Of Sialyl Lewis X and Glycosyltransferases Across the Menstrual Cycle and Early Pregnancy In Human Endometrium.  REPRODUCTIVE SCIENCES.

Human blood dendritic cells are distinguished by potent E-selectin binding capacity.  GLYCOBIOLOGY. 6-6.

Analysis of CD45 Isoforms Displayed By Human Peripheral Blood Mononuclear Cells.  BLOOD. 11202-11202.

FUT1 Knockout Leads to Reduced alpha(1,2)-Fucosylated Epitope Expression and Reduced Receptor Tyrosine Kinase Signaling in Head and Neck Cancer Cells.  GLYCOBIOLOGY. 972-972.

Fucosyltransferase expression is associated with head and neck cancer survival.  CANCER RESEARCH.

Identification of alpha 1,2-Fucosylated glycoproteins in head and neck squamous cell carcinoma.  GLYCOBIOLOGY. 1686-1686.

Abstract 2004: Understanding the role of α1,2-fucosylation in head and neck cancer.  CANCER RESEARCH. 2004-2004.

Understanding the role of α1,2-fucosylation in head and neck cancer..  CANCER RESEARCH.

A missense mutation in SLC39A8, a manganese transporter linked to schizophrenia, is associated with specific changes in plasma N-glycosylation.  GLYCOBIOLOGY. 1050-1050.

CLINICAL TRIAL OF INTRAVENOUS INFUSION OF FUCOSYLATED BONE MARROW MESENCHYMAL STEM CELLS IN PATIENTS WITH OSTEOPOROSIS.  ANNALS OF THE RHEUMATIC DISEASES. 1625-1625.

Mapping Specific Cellular Sialoglycans Using Glycosyltransferases.  FASEB JOURNAL.

INTRAVENOUS INFUSION OF FUCOSYLATED BONE MARROW MESENCHYME CELLS IN PATIENTS WITH OSTEOPOROSIS. PRECLINICAL STUDY IN A MURINE MODEL.  ANNALS OF THE RHEUMATIC DISEASES. 487-487.

Imaging Specific Glycan Epitopes on Cells Using Glycosyltransferases via Click Chemistry.  FASEB JOURNAL.

Analysis of cell surface glycans and associated gene expression in human hematopoietic stem and progenitor cells.  GLYCOBIOLOGY. 1298-1299.

Comparative analysis of enforced a(1,3)-fucosylation using intracellular and extracellular methods.  GLYCOBIOLOGY. 1280-1281.

Selection-Independent regulation of inflammatory cell trafficking by alpha1,3-fucose ligands - modulation of the beta2 integrin axis.  GLYCOBIOLOGY. 1251-1251.

EFFICACY OF OSTEOBLASTOGENESIS IN A MOUSE MODEL INFUSED WITH HUMAN FUCOSYLATED MESENCHYMAL STEM CELLS FROM THE HUMAN BONE MARROW. THE FINAL PRECLINICAL STUDY DATA.  Haematologica. 4-5.

Fucosylated mesenchymal tem cells to treat systemic bone diseases.  Human Gene Therapy. A26-A27.

Fucosylation to control cell fate. Protocol validation under GMP conditions for clinical use.  Human Gene Therapy. A101-A102.

Fucosyltransferase VI Induces Platelet Activation: A Novel Property of a Plasma Glycosyltransferase.  BLOOD. 1542-1542.

Increased Cell Surface Sialidase Activity Drives CD15 Expression during Human Myeloid Cell Differentiation.  GLYCOBIOLOGY. 976-977.

Programming Stem Cell Migration: "Steering" Regenerative Therapeutics by Ex Vivo Glycan Engineering of HCELL.  GLYCOBIOLOGY. 949-949.

Ex vivo glycan engineering of membrane CD44 to create HCELL programs human mesenchymal stem cell trafficking to bone.  BLOOD. 72A-72A.

HCELL is the major E- and L-selectin ligand expressed on human hematopoietic progenitor cells and colon carcinoma cells..  BLOOD. 477A-478A.

Development of late over early full donor chimerism (FDC) results in improved progression-free and overall survival in patients with advanced malignant lymphomas receiving nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT)..  BLOOD. 1020A-1020A.

Comparative analysis of sialomucin and glycolipid E-selectin ligand activities: Effects of HCELL knockdown.  GLYCOBIOLOGY. 1249-1249.

From graft failure to graft-versus-host disease: the central role of glycans in allogeneic bone marrow transplantation.  GLYCOBIOLOGY. 1067-1068.

CD44/HCELL is an E- and L-selectin ligand on murine hematopoietic progenitor cells..  BLOOD. 180B-180B.

G-CSF mobilization radically upregulates alpha-1,3-Fucosyltransferases-4 and -7 generating high avidity E-selectin ligands on circulating nucleated cells..  BLOOD. 115A-115A.

High incidence of peri-engraftment fever and rash in patients after CD8 T cell depleted allogeneic myeloablative peripheral blood stem cell transplantation (PBSCT)..  BLOOD. 710A-710A.

Tolerance and antitumor responses following combined HLA-matched nonmyeloablative bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease..  BLOOD. 728A-728A.

Searching for novel selectin ligands: Identification and characterization of CD43 as a ligand for E-selectin on skin-homing T cells..  ARTHRITIS AND RHEUMATISM. S274-S274.

Ca++ independent T cell adherence to inflamed gingival epithelium detected by a shear-dependent lymphocyte adherence assay.  JOURNAL OF INVESTIGATIVE DERMATOLOGY. 312-312.

Functional modulation of cutaneous lymphocyte-associated antigen on skin-homing lymphocytes and prevention of allergic contact dermatitis with a fluorinated analog of N-acetylglucosamine.  JOURNAL OF INVESTIGATIVE DERMATOLOGY. 342-342.

Identification and characterization of novel E-selectin ligands on skin-homing T cells.  JOURNAL OF INVESTIGATIVE DERMATOLOGY. 303-303.

Expression of selectin ligands on blasts from human acute leukemias.  EXPERIMENTAL HEMATOLOGY. 81-81.

Haploidentical donor BMT for advanced hematologic malignancy (HM) following non-myeloadlative conditioning including in vivo T-cell depletion..  Leukemia. 415-415.

Achievement of sustained remissions despite loss of donor chimerism (DC) in patients with chemotherapy-refractory non-Hodgkin's lymphoma (NHL) treated with nonmyeloablative conditioning and allogeneic stem cell transplantation (SCT)..  BLOOD. 418A-418A.

Durable progression free survival (PFS) following non-myeloablative bone marrow transplantation (BMT) for chemorefractory diffuse large B cell lymphoma (B-LCL)..  BLOOD. 672A-672A.

Effects of mycophenolate mofetil on hematopoietic progenitor cells..  BLOOD. 313B-313B.

Homing and hematopoiesis: HCELL is the principal E-selectin and L-selectin ligand of human hematopoietic stem cells..  BLOOD. 710A-710A.

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-vs-host disease (GvHD) and anti-tumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic stem cell transplantation (SCT)..  BLOOD. 417A-417A.

The induction of sustained allograft tolerance and anti-tumor responses following combined HLA-matched donor bone marrow and renal transplantation for multiple myeloma with end-stage renal disase..  BLOOD. 412A-412A.

Direct observation of E-selectin mediated rolling on cutaneous lymphocyte-associated antigen using a novel blot rolling assay.  JOURNAL OF INVESTIGATIVE DERMATOLOGY. 397-397.

Early predominance of host or donor T-cells correlates with graft failure and GVHD, respectively, in recipients of extensively HLA-mismatched bone marrow transplants following non-myeloablative conditioning..  BLOOD. 522A-522A.

Engraftment syndrome following nonmyeloablative conditioning therapy and HLA-matched bone marrow transplantation (BMT) for hematologic malignancy (HM)..  BLOOD. 520A-520A.

Haploidentical donor bone marrow transplantation (BMT) for advanced hematologic malignancy (HM) following non-myeloablative preparative therapy: Role of in vivo T-cell depletion with anti-thymocyte globulin or anti-CD2 monoclonal antibody therapy (MEDI-507)..  BLOOD. 841A-841A.

Successful second allogeneic marrow transplantation following non-myeloablative conditioning for patients with relapsed/refractory lymphoma after failure of autologous transplant..  BLOOD. 412A-412A.

A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons.  TRANSPLANTATION PROCEEDINGS. 1100-1100.

Can mixed chimerism be achieved without GVHD across HLA barriers using non-myeloablative conditioning with exhaustive in vivo T cell depletion? Preliminary experience in patients with hematological malignancies..  Transplantation. S295-S295.

A novel method for investigation of cellular adhesive interactions with immobilized ligands under flow conditions..  BLOOD. 76B-76B.

Analysis of donor erythropoiesis and recipient RBC isohemagglutinins in major ABO blood group mismatched recipients of a non-myeloablative bone marrow transplant regimen..  BLOOD. 316B-316B.

Association of anti-donor reactive cytotoxic T lymphocyte responses with marrow graft rejection following bone marrow transplantation (BMT) with a novel non-myeloablative conditioning regimen: Evidence for split tolerance in a patient with combined kidney and BMT..  BLOOD. 349A-349A.

Graft-versus-leukemia effects, mixed chimerism and early T-cell reconstitution in two patients with advanced stage chronic lymphocytic leukemia after pone marrow transplantation with a novel nonmyeloablative conditioning regimen..  BLOOD. 349A-349A.

Mixed lymphohematopoietic chimerism following non-myeloablative conditioning and HLA-matched allogeneic bone marrow transplantation (BMT): The effects on chimerism and anti-tumor response of prophylactic donor leukocyte infusion (DLI)..  BLOOD. 709A-709A.

Novel L-selectin ligand activity with unique biophysical characteristics on hematopoietic progenitor cells..  BLOOD. 255A-255A.

Thrombotic thrombocytopenic purpura following peripheral blood progenitor cell xenotransplantation occurs independently of aberrant vWF multimer proteolysis..  BLOOD. 13A-13A.

A thrombotic disorder complicating xenogeneic peripheral blood stem cell transplantation: A primate model of thrombotic thrombocytopenic purpura (TTP)..  BLOOD. 706A-706A.

Characterisation of phenotypic and functional lymphocyte reconstitution in adult patients with chemoradiorefractory hematolocical malignancies (HM) receiving a novel non-myeloablative conditioning therapy and HLA-matched and mismatched donor bone marrow transplantation (BMT)..  BLOOD. 684A-684A.

Mixed lymphohematopoietic chimerism in adult recipients following non-myeloablative therapy and HLA-matched or mismatched donor bone marrow transplantation, and the effect of donor leukocyte infusions..  BLOOD. 520A-520A.

Structural biology of a novel L-selectin ligand expressed on hematopoietic progenitor cells..  BLOOD. 583A-583A.

Divergence of integrin function in hematopoiesis in the pig to human xenogeneic combination: Implications for bone marrow induced donor-specific tolerance.  EXPERIMENTAL HEMATOLOGY. 778-778.

L-SELECTIN-CD34 INTERACTIONS MEDIATE FUNCTIONAL BINDING OF LYMPHOCYTES TO HEMATOPOIETIC PROGENITOR CELLS.  Clinical Research. A235-A235.

PHYSIOLOGICAL MIGRATION OF LYMPHOCYTES TO LYMPH-NODES FOLLOWING BONE-MARROW TRANSPLANTATION - ROLE IN IMMUNE RECOVERY.  Seminars in Oncology. 34-39.

STEROID-ASSOCIATED CHANGES IN LYMPHOCYTE ADHESION MOLECULE EXPRESSION - EFFECTS ON L-SELECTIN, CD44 AND LFA-1.  Clinical Research. A374-A374.

ANALYSIS OF TQ-1 AND LEU-8 EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA.  Clinical Research. A436-A436.

LYMPHOCYTE HOMING RECEPTORS - STRUCTURAL STUDIES AND EVIDENCE FOR POSTTRANSCRIPTIONAL REGULATION OF EXPRESSION.  Clinical Research. A589-A589.

LYMPHOCYTE ADHERENCE TO PSORIATIC DERMAL ENDOTHELIUM - EFFECTS OF ULTRAVIOLET-LIGHT THERAPY.  Clinical Research. A551-A551.

ISOLATION AND NUCLEOTIDE SEQUENCING OF MOUSE FACTOR-B CDNA - EVIDENCE FOR PHYLOGENETIC CONSERVATION OF BF.  Immunobiology. 292-292.

Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis.  Haematologica. E54-E58.

Re: "Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ^null mice.  EXPERIMENTAL HEMATOLOGY. 518-519.

Untitled.  EXPERIMENTAL HEMATOLOGY. 698-699.

Untitled - Response.  EXPERIMENTAL HEMATOLOGY. 699-699.

Real-time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy.  JOURNAL OF INVESTIGATIVE DERMATOLOGY. 384-386.

Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70:1323.  Transplantation. 1273-1274.

DETECTION OF AN L-SELECTIN LIGAND ON A HEMATOPOIETIC PROGENITOR-CELL LINE.  BLOOD. 3299-3306.

Realizing the promise of 'La Dolce Vita' via chemical biology: glycan-motif editing of sLe^X for precision cancer therapeutics.  The FEBS Journal. 3616-3628.

E-selectin binding is enriched within B-cell acute lymphoblastic leukemia compared to healthy lymphoid precursors.  CANCER RESEARCH.

Enforced HCELL expression: empowering "Step 1" to optimize the efficacy of mesenchymal stem/stromal cell therapy for stroke and other clinical conditions.  Stem Cells. 1027-1030.

Differential CD45 isoform expression and function in AML versus healthy leukocytes.  CANCER RESEARCH.

Enrichment and Analysis of Head and Neck Cancer Mucin-Domain Glycoproteins Reveals the Presence of Tumor-Derived Immunoglobulin A.  Journal of Biological Chemistry. S370-S370.

Association Between Glycosyltransferase Expression and Survival in Head and Neck Cancer.  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. E30-E30.

HUMAN BONE MARROW MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES MODIFIED BY ENZYMATIC EXOFUCOSYLATION PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE PROGRESSION.  Cytotherapy. S25-S26.

MESENCHYMAL STEM CELL IMMUNOREGULATORY EFFECTS ARE BOOSTED BY CD44 LIGATION.  Cytotherapy. S129-S130.

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (vol 10, 1151, 2019).  FRONTIERS IN IMMUNOLOGY.

Florida International University Herbert Wertheim College of Medicine.  ACADEMIC MEDICINE. S103-S106.

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics.  BLOOD.

GLYCOENGINEERING OF E-SELECTIN LIGANDS BY INTRINSIC VERSUS EXTRINSIC FUCOSYLATION DIFFERENTIALLY AFFECTS OSTEOTROPISM OF HUMAN MESENCHYMAL STEM CELLS.  EXPERIMENTAL HEMATOLOGY. S68-S68.

Translational glycobiology: Patient-oriented glycoscience research INTRODUCTION.  GLYCOBIOLOGY. 544-545.

Training the next generation of biomedical investigators in glycosciences.  Journal of Clinical Investigation. 405-408.

Hitting the sweet spot for lymphoma.  BLOOD. 4626-4627.

Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions (vol 86, pg 1285, 2009).  JOURNAL OF LEUKOCYTE BIOLOGY. 534-534.

CD15 (Lewis x) expression in human myeloid cell differentiation is regulated by sialidase activity..  BLOOD. 546A-547A.

Effects of thymoglobulin on lymphocyte L-selectin-mediated adhesive interactions.  Transplantation and Cellular Therapy. 79-80.

Defining the bone marrow stem cell niche according to a Hoechst dye diffusion gradient and hypoxia..  BLOOD. 192A-192A.

The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing.  Journal of Investigative Dermatology Symposium Proceedings. 215-223.

Xenotransplantation so close, but yet so far.  Transplantation. 1-2.

A new method for identification of adhesive interactions under shear force conditions.  EXPERIMENTAL HEMATOLOGY. 35-35.

Prevention of humoral sensitization to transplanted pig hematopoietic cells in baboons.  Transplantation. S613-S613.

Porcine cells adhere to human fibronectin independently of VLA-5: Implications for porcine to human xenotransplantation..  Transplantation. S134-S134.

Porcine peripheral blood stem cell transplantation in baboons is complicated by thrombotic thrombocytopenic purpura.  Transplantation. S134-S134.

Detection of a novel L-selectin ligand on normal human hematopoietic progenitor cells..  JOURNAL OF INVESTIGATIVE MEDICINE. A215-A215.

Leptin Secreted from Testicular Microenvironment Modulates Hedgehog Signaling to Augment the Endogenous Function of Leydig Cells

The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation

Imaging specific cellular glycan structures using glycosyltransferases via click chemistry

Structure, function, and implications of fucosyltransferases in health and disease.  NATURE COMMUNICATIONS.

Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseases.  JOURNAL OF LEUKOCYTE BIOLOGY.

Chemical Strategies to Custom-Modify α(1→3)-Fucosylated Glycan Motifs of the Human Glycocalyx.  JACS Au. 4637-4654.

Review ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies.  iScience.

Recent advances on smart glycoconjugate vaccines in infections and cancer.  The FEBS Journal. 4251-4303.

Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.  Journal of Histochemistry and Cytochemistry. 749-773.

E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.  FRONTIERS IN IMMUNOLOGY.

Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology.  GLYCOBIOLOGY. 560-570.

Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.  Current Opinion in Hematology. 317-323.

CD44 and HCELL: Preventing hematogenous metastasis at step 1.  FEBS Letters. 3148-3158.

Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration.  IMMUNOLOGICAL REVIEWS. 51-74.

The blot rolling assay: a method for identifying adhesion molecules mediating binding under shear conditions..  Methods in molecular biology (Clifton, N.J.). 217-226.

Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow.  EXPERIMENTAL HEMATOLOGY. 327-339.

Physiologic migration of lymphocytes to lymph nodes following bone marrow transplantation: Role in immune recovery.  Seminars in Oncology. 34-39.

Cardiac pacing and atrial arrhythmias.  Cardiology Clinics. 609-617.

LYMPHOCYTE-HOMING RECEPTORS AND PREFERENTIAL MIGRATION PATHWAYS.  Experimental Biology and Medicine. 374-380.

Specific lymphocyte-endothelial cell interactions regulate migration into lymph nodes, Peyer's patches, and skin..  Regional Immunology. 78-83.

MOLECULAR-BIOLOGY OF THE HUMAN AND MOUSE MHC CLASS-III GENES - PHYLOGENETIC CONSERVATION, GENETICS AND REGULATION OF EXPRESSION.  IMMUNOLOGICAL REVIEWS. 185-208.